Eaton Vance Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $393K | Sell |
|
|||||
|
2022
Q2 | $476K | Sell |
|
|||||
|
2022
Q1 | $911K | Buy |
|
|||||
|
2021
Q4 | $413K | Hold |
|
|||||
|
2021
Q3 | $1.57M | Hold |
|
|||||
|
2021
Q2 | $2.21M | Sell |
|
|||||
|
2021
Q1 | $1.59M | Buy |
|
|||||
|
2020
Q4 | $1.93M | Sell |
|
|||||
|
2020
Q3 | $1.53M | Hold |
|
|||||
|
2020
Q2 | $2.44M | Buy |
|
|||||
|
2020
Q1 | $2.26M | Hold |
|
|||||
|
2019
Q4 | $3.2M | Buy |
|
|||||
|
2019
Q3 | $879K | Hold |
|
|||||
|
2019
Q2 | $1.03M | Buy |
|